{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:28:30Z","timestamp":1790504910304,"version":"4.1.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00892","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:27:28Z","timestamp":1598005648000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review"],"prefix":"10.3389","volume":"14","author":[{"given":"Jun Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsic","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Joon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archopht.1997.01100150233013","article-title":"Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene.","volume":"115","author":"Abe","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s004170100342","article-title":"Ophthalmological findings in patients with spinocerebellar ataxia type 1 are not correlated with neurological anticipation.","volume":"239","author":"Abe","year":"2001","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/hmg\/ddi483","article-title":"Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program.","volume":"15","author":"Abou-Sleymane","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ajo.2004.10.055","article-title":"Anatomical and functional characteristics in atrophic maculopathy associated with spinocerebellar ataxia type 7.","volume":"139","author":"Ahn","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/exer.2002.1169","article-title":"Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype.","volume":"74","author":"Aleman","year":"2002","journal-title":"Exp. Eye Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/eye.2013.201","article-title":"Optical coherence tomography findings in spinocerebellar ataxia-3.","volume":"27","author":"Alvarez","year":"2013","journal-title":"Eye"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?","volume":"19","author":"Alves","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1590\/0004-282x20170146","article-title":"Impact of disease duration on functional status of patients with spinocerebellar ataxia type 2.","volume":"75","author":"Amarante","year":"2017","journal-title":"Arq. Neuropsiquiatr."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.021","article-title":"Gene therapy for retinal degeneration.","volume":"173","author":"Apte","year":"2018","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1212\/CON.0000000000000362","article-title":"Ataxia.","volume":"22","author":"Ashizawa","year":"2016","journal-title":"Continuum"},{"key":"B11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s12311-019-1004-3","article-title":"Ophthalmological and neurologic manifestations in pre-clinical and clinical phases of spinocerebellar ataxia type 7.","volume":"18","author":"Azevedo","year":"2019","journal-title":"Cerebellum"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1167\/iovs.11-7509","article-title":"Rod sensitivity, cone sensitivity, and photoreceptor layer thickness in retinal degenerative diseases.","volume":"52","author":"Birch","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1101\/gad.250225.114","article-title":"The SAGA coactivator complex acts on the whole transcribed genome and is required for RNA polymerase II transcription.","volume":"28","author":"Bonnet","year":"2014","journal-title":"Genes Dev"},{"key":"B14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0959-440X(96)80097-2","article-title":"The TATA box binding protein.","volume":"6","author":"Burley","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/archneur.55.10.1353","article-title":"Oculomotor phenotypes in autosomal dominant ataxias.","volume":"55","author":"Buttner","year":"1998","journal-title":"Arch. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/eye.2017.135","article-title":"Ophthalmic features of spinocerebellar ataxia type 7.","volume":"32","author":"Campos-Romo","year":"2018","journal-title":"Eye"},{"key":"B17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/hmg\/ddy401","article-title":"Loss of zebrafish Ataxin-7, a SAGA subunit responsible for SCA7 retinopathy, causes ocular coloboma and malformation of photoreceptors.","volume":"28","author":"Carrillo-Rosas","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1074\/jbc.m310939200","article-title":"Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.","volume":"279","author":"Chai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archneur.65.4.530","article-title":"Impaired eye movements in presymptomatic spinocerebellar ataxia type 6.","volume":"65","author":"Christova","year":"2008","journal-title":"Arch. Neurol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.15788.1","article-title":"Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.","volume":"7","author":"Coarelli","year":"2018","journal-title":"F1000Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/hmg\/ddy359","article-title":"Prph2 initiates outer segment morphogenesis but maturation requires Prph2\/Rom1 oligomerization.","volume":"28","author":"Conley","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/mt.2013.144","article-title":"Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.","volume":"21","author":"Costa Mdo","year":"2013","journal-title":"Mol. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ng0997-65","article-title":"Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.","volume":"17","author":"David","year":"1997","journal-title":"Nat. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10072-003-0112-4","article-title":"Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17.","volume":"24","author":"De Michele","year":"2003","journal-title":"Neurol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12311-011-0315-9","article-title":"Infantile childhood onset of spinocerebellar ataxia type 2.","volume":"11","author":"Di Fabio","year":"2012","journal-title":"Cerebellum"},{"key":"B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12311-013-0527-2","article-title":"Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.","volume":"13","author":"Doss","year":"2014","journal-title":"Cerebellum"},{"key":"B27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/archopht.1992.01080170134041","article-title":"Progression of retinopathy in olivopontocerebellar atrophy with retinal degeneration.","volume":"110","author":"Drack","year":"1992","journal-title":"Arch. Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/brain\/awl081","article-title":"Molecular pathogenesis of spinocerebellar ataxias.","volume":"129","author":"Duenas","year":"2006","journal-title":"Brain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/hmg\/ddq452","article-title":"The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.","volume":"20","author":"Durcan","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s13311-019-00777-6","article-title":"Molecular mechanisms and therapeutics for spinocerebellar ataxia type 2.","volume":"16","author":"Egorova","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/brain\/awr009","article-title":"Differences in saccade dynamics between spinocerebellar ataxia 2 and late-onset cerebellar ataxias.","volume":"134","author":"Federighi","year":"2011","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/wnl.55.4.569","article-title":"Late-onset SCA2: 33 CAG repeats are sufficient to cause disease.","volume":"55","author":"Fernandez","year":"2000","journal-title":"Neurology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/35040584","article-title":"Identification of genes that modify ataxin-1-induced neurodegeneration.","volume":"408","author":"Fernandez-Funez","year":"2000","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8283","DOI":"10.1074\/jbc.m709674200","article-title":"Polyglutamine expansion reduces the association of TATA-binding protein with DNA and induces DNA binding-independent neurotoxicity.","volume":"283","author":"Friedman","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0950","article-title":"Optical coherence tomography: a window into the mechanisms of multiple sclerosis.","volume":"4","author":"Frohman","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12311-008-0027-y","article-title":"Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.","volume":"7","author":"Garden","year":"2008","journal-title":"Cerebellum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s0079-6123(08)00683-3","article-title":"The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype).","volume":"171","author":"Geiner","year":"2008","journal-title":"Prog. Brain Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ng0793-295","article-title":"Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1.","volume":"4","author":"Gispert","year":"1993","journal-title":"Nat. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ana.410420616","article-title":"Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset.","volume":"42","author":"Gomez","year":"1997","journal-title":"Ann. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12311-012-0412-4","article-title":"Spinocerebellar ataxia type 7: clinical course, phenotype\u2013genotype correlations, and neuropathology.","volume":"12","author":"Horton","year":"2013","journal-title":"Cerebellum"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1212\/01.wnl.0000276958.91986.89","article-title":"Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17).","volume":"69","author":"H\u00fcbner","year":"2007","journal-title":"Neurology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13816810802454081","article-title":"Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7).","volume":"30","author":"Hugosson","year":"2009","journal-title":"Ophthalmic Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"15200","DOI":"10.1073\/pnas.222362099","article-title":"Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development.","volume":"99","author":"Ieraci","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s13311-019-00804-6","article-title":"Molecular mechanisms and future therapeutics for spinocerebellar ataxia type 31 (SCA31).","volume":"16","author":"Ishikawa","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archneur.58.6.899","article-title":"Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n.","volume":"58","author":"Jardim","year":"2001","journal-title":"Arch. Neurol."},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1186\/s40673-018-0095-9","article-title":"Slow saccades in cerebellar disease.","volume":"6","author":"Jensen","year":"2019","journal-title":"Cerebellum Ataxias"},{"key":"B47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10059-009-0095-y","article-title":"Molecular pathogenesis of spinocerebellar ataxia type 1 disease.","volume":"27","author":"Kang","year":"2009","journal-title":"Mol. Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/mt.2013.279","article-title":"Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.","volume":"22","author":"Keiser","year":"2014","journal-title":"Mol. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nbd.2013.04.003","article-title":"RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.","volume":"56","author":"Keiser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/brain\/awv292","article-title":"Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.","volume":"138","author":"Keiser","year":"2015","journal-title":"Brain"},{"key":"B51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrneurol.2014.79","article-title":"Ophthalmic manifestations of inherited neurodegenerative disorders.","volume":"10","author":"Kersten","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/mds.25464","article-title":"Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features.","volume":"28","author":"Kim","year":"2013","journal-title":"Mov. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/s0006-291x(03)01241-5","article-title":"Polyglutamine-expanded ataxin-1 recruits Cu\/Zn-superoxide dismutase into the nucleus of HeLa cells.","volume":"307","author":"Kim","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B54","article-title":"Spinocerebellar ataxia.","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/hmg\/8.11.2047","article-title":"A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?","volume":"8","author":"Koide","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B56","article-title":"From mild ataxia to huntington disease phenocopy: the multiple faces of spinocerebellar ataxia 17.","volume":"2014","author":"Koutsis","year":"2014","journal-title":"Case Rep. Neurol. Med."},{"key":"B57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/bjo.2009.162586","article-title":"High-definition spectral domain optical coherence tomography in the evaluation of ataxia with visual impairment.","volume":"95","author":"Kumar","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/s0896-6273(01)00422-6","article-title":"Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.","volume":"31","author":"La Spada","year":"2001","journal-title":"Neuron"},{"key":"B59","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuroscience.2018.12.051","article-title":"Cell death mechanisms in a mouse model of retinal degeneration in spinocerebellar ataxia 7.","volume":"400","author":"Lebon","year":"2019","journal-title":"Neuroscience"},{"key":"B60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/wno.0b013e31828d4add","article-title":"Maculopathy and spinocerebellar ataxia type 1: a new association?","volume":"33","author":"Lebranchu","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"13116","DOI":"10.1074\/jbc.m707697200","article-title":"Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.","volume":"283","author":"Lee","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2016.03.005","article-title":"Safety and efficacy of valproic acid treatment in SCA3\/MJD patients.","volume":"26","author":"Lei","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s10495-013-0862-2","article-title":"Apoptosis-inducing factor (AIF) and leukocyte elastase inhibitor\/L-DNase II (LEI\/LDNaseII), can interact to conduct caspase-independent cell death.","volume":"18","author":"Lepr\u00eatre","year":"2013","journal-title":"Apoptosis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/icb.0000000000000248","article-title":"Multimodal imaging of a family with spinocerebellar ataxia type 7 demonstrating phenotypic variation and progression of retinal degeneration.","volume":"10","author":"Levinson","year":"2016","journal-title":"Retin. Cases Brief Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s13311-019-00762-z","article-title":"Molecular mechanisms and therapeutics for SCA17.","volume":"16","author":"Liu","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00041327-200212000-00007","article-title":"Practical approaches to neurogenetic disease.","volume":"22","author":"Lynch","year":"2002","journal-title":"J. Neuroophthalmol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1172\/jci74770","article-title":"Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model.","volume":"125","author":"Maltecca","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B68","first-page":"198","article-title":"Cone dystrophy or macular dystrophy associated with novel autosomal dominant GUCA1A mutations.","volume":"23","author":"Manes","year":"2017","journal-title":"Mol. Vis."},{"key":"B69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WNO.0b013e3181b2828e","article-title":"Ophthalmic features of spinocerebellar ataxia type 7.","volume":"29","author":"Manrique","year":"2009","journal-title":"J. Neuroophthalmol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1007\/s00415-007-0579-7","article-title":"Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.","volume":"254","author":"Mariotti","year":"2007","journal-title":"J. Neurol."},{"key":"B71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/mdc3.12274","article-title":"Dystonia in patients with spinocerebellar ataxia type 2.","volume":"3","author":"Markovic","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1076327","article-title":"RNA polymerase II transcription in murine cells lacking the TATA binding protein.","volume":"298","author":"Martianov","year":"2002","journal-title":"Science"},{"key":"B73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/B978-0-444-51892-7.00030-9","article-title":"Spinocerebellar ataxia type 7.","volume":"103","author":"Martin","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1113\/jp271897","article-title":"Cellular and circuit mechanisms underlying spinocerebellar ataxias.","volume":"594","author":"Meera","year":"2016","journal-title":"J. Physiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.ejhg.5201108","article-title":"Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.","volume":"12","author":"Michalik","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/wno.0b013e3181b1b3f8","article-title":"Neuro-ophthalmologic features of spinocerebellar ataxia type 7.","volume":"29","author":"Miller","year":"2009","journal-title":"J. Neuroophthalmol."},{"key":"B78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf5660","article-title":"An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.","volume":"8","author":"Miyazaki","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B79","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/0972-2327.116896","article-title":"An update on Spino-cerebellar ataxias.","volume":"16","author":"Mondal","year":"2013","journal-title":"Ann. Indian Acad. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"15134","DOI":"10.1523\/jneurosci.4720-09.2009","article-title":"Posttranslational modification of ataxin-7 at lysine 257 prevents autophagy-mediated turnover of an N-terminal caspase-7 cleavage fragment.","volume":"29","author":"Mookerjee","year":"2009","journal-title":"J. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/wno.0000000000000167","article-title":"Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study.","volume":"35","author":"Moscovich","year":"2015","journal-title":"J. Neuroophthalmol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s13311-019-00778-5","article-title":"Molecular targets and therapeutic strategies in spinocerebellar ataxia type 7.","volume":"16","author":"Niewiadomska-Cimicka","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/13816810.2019.1571614","article-title":"Macular degeneration as a common cause of visual loss in spinocerebellar ataxia type 1 (SCA1) patients.","volume":"40","author":"Nishiguchi","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8677","article-title":"Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.","volume":"10","author":"Niu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B85","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/mdc3.12949","article-title":"Functionally relevant maculopathy and optic atrophy in spinocerebellar ataxia type 1.","volume":"7","author":"Oertel","year":"2020","journal-title":"Mov. Disord. Clin Pract."},{"key":"B86","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.1059","article-title":"Slowing of voluntary and involuntary saccades: an early sign in spinocerebellar ataxia type 7.","volume":"49","author":"Oh","year":"2001","journal-title":"Ann. Neurol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/s40673-018-0086-x","article-title":"Spinocerebellar ataxia 17: full phenotype in a 41 CAG\/CAA repeats carrier.","volume":"5","author":"Origone","year":"2018","journal-title":"Cerebellum Ataxias"},{"key":"B88","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.","volume":"4","author":"Orr","year":"1993","journal-title":"Nat. Genet."},{"key":"B89","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/13816810.2019.1633548","article-title":"Spinocerebellar ataxia type 7 with RP1L1-negative occult macular dystrophy as retinal manifestation.","volume":"40","author":"Park","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"B90","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/WNO0b013e3181b416de","article-title":"The spinocerebellar ataxias.","volume":"29","author":"Paulson","year":"2009","journal-title":"J. Neuroophthalmol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-3-319-71779-1_6","article-title":"Spinocerebellar ataxia type 1: molecular mechanisms of neurodegeneration and preclinical studies.","volume":"1049","author":"Perez Ortiz","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0022-510x(96)00140-2","article-title":"Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients.","volume":"142","author":"Perretti","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/archneur.1978.00500270038008","article-title":"Dominant spinopontine atrophy. Report of two additional members of family W.","volume":"35","author":"Pogacar","year":"1978","journal-title":"Arch. Neurol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00274","article-title":"Anti-saccades in cerebellar ataxias reveal a contribution of the cerebellum in executive functions.","volume":"9","author":"Pretegiani","year":"2018","journal-title":"Front. Neurol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/icu.0b013e32833eaf71","article-title":"Ophthalmologic features of the common spinocerebellar ataxias.","volume":"21","author":"Pula","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/01658107.2011.580898","article-title":"Retinal nerve fibre layer and macular thinning in spinocerebellar ataxia and cerebellar multisystem atrophy.","volume":"35","author":"Pula","year":"2011","journal-title":"Neuroophthalmology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095362","article-title":"RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.","volume":"9","author":"Ramachandran","year":"","journal-title":"PLoS One"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/mt.2014.108","article-title":"Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.","volume":"22","author":"Ramachandran","year":"","journal-title":"Mol. Ther."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-17","article-title":"Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD\/SCA3).","volume":"14","author":"Raposo","year":"2014","journal-title":"BMC Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s12311-020-01120-y","article-title":"The pathophysiology and clinical manifestations of spinocerebellar ataxia type 6.","volume":"19","author":"Rentiya","year":"2020","journal-title":"Cerebellum"},{"key":"B101","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s004010050371","article-title":"Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype.","volume":"90","author":"Robitaille","year":"1995","journal-title":"Acta Neuropathol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jns.2011.03.033","article-title":"Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions.","volume":"306","author":"Rodr\u00edguez-Labrada","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"B103","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice.","volume":"21","author":"Rodriguez-Lebron","year":"2013","journal-title":"Mol. Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.10676","article-title":"Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).","volume":"54","author":"Rolfs","year":"2003","journal-title":"Ann. Neurol."},{"key":"B105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","article-title":"Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.","volume":"14","author":"Romano","year":"2015","journal-title":"Lancet Neurol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s10072-020-04318-4","article-title":"Eye movement changes in autosomal dominant spinocerebellar ataxias.","volume":"41","author":"Rosini","year":"2020","journal-title":"Neurol. Sci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000047968","article-title":"Spinocerebellar ataxia type 2 (SCA2) associated with retinal pigmentary degeneration.","volume":"47","author":"Rufa","year":"2002","journal-title":"Eur. Neurol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12311-008-0024-1","article-title":"Electrophysiology in spinocerebellar ataxias: spread of disease and characteristic findings.","volume":"7","author":"Sch\u00f6ls","year":"2008","journal-title":"Cerebellum"},{"key":"B109","first-page":"707","article-title":"Oligonucleotide therapeutics in neurodegenerative diseases.","volume":"15","author":"Scoles","year":"2018","journal-title":"RNA Biol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","article-title":"Brain pathology of spinocerebellar ataxias.","volume":"124","author":"Seidel","year":"2012","journal-title":"Acta Neuropathol."},{"key":"B111","first-page":"139","article-title":"Epidemiology and clinical aspects of Machado-Joseph disease.","volume":"61","author":"Sequeiros","year":"1993","journal-title":"Adv. Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1399-0004.2004.00356.x","article-title":"Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease.","volume":"66","author":"Shatunov","year":"2004","journal-title":"Clin. Genet."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135275","article-title":"The pathogenic role of low range repeats in SCA17.","volume":"10","author":"Shin","year":"2015","journal-title":"PLoS One"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100779","article-title":"Retinal stem cell transplantation: Balancing safety and potential.","volume":"75","author":"Singh","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12311-017-0856-7","article-title":"A comparative optical coherence tomography study of spinocerebellar ataxia types 3 and 10.","volume":"16","author":"Spina Tensini","year":"2017","journal-title":"Cerebellum"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s12311-019-01044-2","article-title":"Eye movement abnormalities are ubiquitous in the spinocerebellar ataxias.","volume":"18","author":"Stephen","year":"2019","journal-title":"Cerebellum"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023024","article-title":"Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1.","volume":"6","author":"Stricker","year":"2011","journal-title":"PLoS One"},{"key":"B118","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cge.12808","article-title":"Spinocerebellar ataxia: relationship between phenotype and genotype - a review.","volume":"90","author":"Sun","year":"2016","journal-title":"Clin. Genet."},{"key":"B119","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2174\/1871527318666190311155846","article-title":"Clinical characteristics and possible drug targets in autosomal dominant spinocerebellar ataxias.","volume":"18","author":"Szpisjak","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B120","doi-asserted-by":"publisher","first-page":"443","DOI":"10.6061\/clinics\/2012(05)07","article-title":"Spinocerebellar ataxias: genotype-phenotype correlations in 104 Brazilian families.","volume":"67","author":"Teive","year":"2012","journal-title":"Clinics"},{"key":"B121","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archophthalmol.2011.172","article-title":"Rod-cone dystrophy in spinocerebellar ataxia type 1.","volume":"129","author":"Thurtell","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/wno.0b013e3181b41764","article-title":"Two patients with spinocerebellar ataxia type 7 presenting with profound binocular visual loss yet minimal ophthalmoscopic findings.","volume":"29","author":"Thurtell","year":"2009","journal-title":"J. Neuroophthalmol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-319-71779-1_10","article-title":"Spinocerebellar ataxia type 17 (SCA17).","volume":"1049","author":"Toyoshima","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"B124","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamaophthalmol.2013.1127","article-title":"Novel maculopathy in patients with spinocerebellar ataxia type 1 autofluorescence findings and functional characteristics.","volume":"131","author":"Vaclavik","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2007.07.013","article-title":"Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2.","volume":"263","author":"Velazquez Perez","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.clinph.2008.12.040","article-title":"Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2.","volume":"120","author":"Vel\u00e1zquez-P\u00e9rez","year":"2009","journal-title":"Clin. Neurophysiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.20220","article-title":"Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2.","volume":"56","author":"Vel\u00e1zquez-P\u00e9rez","year":"2004","journal-title":"Ann. Neurol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1006\/nbdi.1999.0248","article-title":"Regulation of calcium channel alpha(1A) subunit splice variant mRNAs in kainate-induced temporal lobe epilepsy.","volume":"6","author":"Vigues","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2217\/epi.14.22","article-title":"Functions of SAGA in development and disease.","volume":"6","author":"Wang","year":"2014","journal-title":"Epigenomics"},{"key":"B130","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050705","article-title":"Requirement for zebrafish ataxin-7 in differentiation of photoreceptors and cerebellar neurons.","volume":"7","author":"Yanicostas","year":"2012","journal-title":"PLoS One"},{"key":"B132","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nbd.2010.06.005","article-title":"Polyglutamine toxicity induces rod photoreceptor division, morphological transformation or death in spinocerebellar ataxia 7 mouse retina.","volume":"40","author":"Yefimova","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0896-6273(02)01190-x","article-title":"SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity.","volume":"37","author":"Yoo","year":"2003","journal-title":"Neuron"},{"key":"B134","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/hmg\/9.17.2491","article-title":"Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice.","volume":"9","author":"Yvert","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"B135","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","article-title":"Glutamine repeats and neurodegeneration.","volume":"23","author":"Zoghbi","year":"2000","journal-title":"Annu. Rev. Neurosci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00892\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:27:35Z","timestamp":1598005655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00892\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,21]]},"references-count":135,"alternative-id":["10.3389\/fnins.2020.00892"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00892","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,21]]},"article-number":"892"}}